| Nanoparticle and targeted systems for cancer therapy L Brannon-Peppas, JO Blanchette Advanced drug delivery reviews 56 (11), 1649-1659, 2004 | 3411 | 2004 |
| Hydrogels for oral delivery of therapeutic proteins NA Peppas, KM Wood, JO Blanchette Expert opinion on biological therapy 4 (6), 881-887, 2004 | 215 | 2004 |
| CAIR-1/BAG-3 forms an EGF-regulated ternary complex with phospholipase C-γ and Hsp70/Hsc70 H Doong, J Price, YS Kim, C Gasbarre, J Probst, LA Liotta, J Blanchette, ... Oncogene 19 (38), 4385-4395, 2000 | 183 | 2000 |
| Principles of transmucosal delivery of therapeutic agents J Blanchette, N Kavimandan, NA Peppas Biomedicine & pharmacotherapy 58 (3), 142-151, 2004 | 129 | 2004 |
| The granulin-epithelin precursor/PC-cell-derived growth factor is a growth factor for epithelial ovarian cancer MB Jones, CM Michener, JO Blanchette, VA Kuznetsov, M Raffeld, ... Clinical cancer research 9 (1), 44-51, 2003 | 108 | 2003 |
| Angiogenesis in ovarian cancer MR Brown, JO Blanchette, EC Kohn Best Practice & Research Clinical Obstetrics & Gynaecology 14 (6), 901-918, 2000 | 89 | 2000 |
| Integrin‐linked kinase production prevents anoikis in human mesenchymal stem cells DSW Benoit, MC Tripodi, JO Blanchette, SJ Langer, LA Leinwand, ... Journal of Biomedical Materials Research Part A: An Official Journal of The …, 2007 | 67 | 2007 |
| Oral chemotherapeutic delivery: design and cellular response J Blanchette, NA Peppas Annals of biomedical engineering 33, 142-149, 2005 | 60 | 2005 |
| Use of culture geometry to control hypoxia-induced vascular endothelial growth factor secretion from adipose-derived stem cells: optimizing a cell-based approach to drive … ML Skiles, S Sahai, L Rucker, JO Blanchette Tissue Engineering Part A 19 (21-22), 2330-2338, 2013 | 51 | 2013 |
| Polarity as a physiological modulator of cell function ME Piroli, JO Blanchette, E Jabbarzadeh Frontiers in bioscience (Landmark edition) 24, 451, 2019 | 45 | 2019 |
| Strategies to direct angiogenesis within scaffolds for bone tissue engineering GM Harris, K Rutledge, Q Cheng, J Blanchette, E Jabbarzadeh Current pharmaceutical design 19 (19), 3456-3465, 2013 | 40 | 2013 |
| Modulation of inflammatory response to implanted biomaterials using natural compounds M Yanez, J Blanchette, E Jabbarzadeh Current Pharmaceutical Design 23 (41), 6347-6357, 2017 | 39 | 2017 |
| Cellular evaluation of oral chemotherapy carriers J Blanchette, NA Peppas Journal of Biomedical Materials Research Part A: An Official Journal of The …, 2005 | 32 | 2005 |
| Vascularization of biomaterials for bone tissue engineering: current approaches and major challenges E Jabbarzadeh, J Blanchette, T Shazly, A Khademhosseini, ... Current Angiogenesis 1 (3), 180-191, 2012 | 23 | 2012 |
| Correlating hypoxia with insulin secretion using a fluorescent hypoxia detection system ML Skiles, R Fancy, P Topiwala, S Sahai, JO Blanchette Journal of Biomedical Materials Research Part B: Applied Biomaterials 97 (1 …, 2011 | 22 | 2011 |
| ASC spheroid geometry and culture oxygenation differentially impact induction of preangiogenic behaviors in endothelial cells ML Skiles, B Hanna, L Rucker, A Tipton, A Brougham-Cook, ... Cell transplantation 24 (11), 2323-2335, 2015 | 21 | 2015 |
| Osteogenic differentiation of adipose-derived stem cells is hypoxia-inducible factor-1 independent S Sahai, A Williams, ML Skiles, JO Blanchette Tissue Engineering Part A 19 (13-14), 1583-1591, 2013 | 17 | 2013 |
| Tracking hypoxic signaling in encapsulated stem cells S Sahai, R McFarland, ML Skiles, D Sullivan, A Williams, JO Blanchette Tissue Engineering Part C: Methods 18 (7), 557-565, 2012 | 12 | 2012 |
| Tracking hypoxic signaling within encapsulated cell aggregates ML Skiles, S Sahai, JO Blanchette JoVE (Journal of Visualized Experiments), e3521, 2011 | 12 | 2011 |
| Use of integrin-linked kinase to extend function of encapsulated pancreatic tissue JO Blanchette, SJ Langer, S Sahai, PS Topiwala, LL Leinwand, ... Biomedical Materials 5 (6), 061001, 2010 | 7 | 2010 |
